In the present study, we discovered that wogonin strongly inhibited MM-stimulated angiogenesis in vivo and in vitro via c-Myc/HIF-1α/VEGF signaling axis, suggesting that these findings may provide a rationale for wogonin's application in the treatment of MM. This evidence concerns the gene MYC and Miyoshi myopathy.